These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32420759)

  • 1. Synergistic Induction of Apoptosis by Quercetin and Curcumin in Chronic Myeloid Leukemia (K562) Cells: II. Signal Transduction Pathways Involved.
    Mutlu Altundağ E; Yılmaz AM; Serdar BS; Jannuzzi AT; Koçtürk S; Yalçın AS
    Nutr Cancer; 2021; 73(4):703-712. PubMed ID: 32420759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Induction of Apoptosis by Quercetin and Curcumin in Chronic Myeloid Leukemia (K562) Cells.
    Mutlu Altundağ E; Yılmaz AM; Koçtürk S; Taga Y; Yalçın AS
    Nutr Cancer; 2018 Jan; 70(1):97-108. PubMed ID: 29161179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe.
    Martinez-Castillo M; Bonilla-Moreno R; Aleman-Lazarini L; Meraz-Rios MA; Orozco L; Cedillo-Barron L; Cordova EJ; Villegas-Sepulveda N
    PLoS One; 2016; 11(11):e0165971. PubMed ID: 27832139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling.
    Hao G; Zhai J; Jiang H; Zhang Y; Wu M; Qiu Y; Fan C; Yu L; Bai S; Sun L; Yang Z
    Biomed Pharmacother; 2020 Feb; 122():109677. PubMed ID: 31810012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin Promotes Cell Cycle Arrest and Apoptosis and Attenuates the Proliferation of Human Chronic Myeloid Leukemia Cell Line-K562 Through Interaction with HSPs (70 and 90), MAT2A and FOXM1.
    Hassanzadeh A; Hosseinzadeh E; Rezapour S; Vahedi G; Haghnavaz N; Marofi F
    Anticancer Agents Med Chem; 2019; 19(12):1523-1534. PubMed ID: 31362681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic Analysis of Quercetin-Treated K562 Cells.
    Brisdelli F; Di Francesco L; Giorgi A; Lizzi AR; Luzi C; Mignogna G; Bozzi A; Schininà ME
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated expression of Cdc6 as BCR/ABL-dependent survival factor in chronic myeloid leukemia cells.
    Zhang JH; He YL; Zhu R; Du W; Xiao JH
    Tumour Biol; 2017 Jun; 39(6):1010428317713394. PubMed ID: 28639894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
    Wei YL; Liang Y; Xu L; Zhao XY
    Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells.
    Reuter S; Charlet J; Juncker T; Teiten MH; Dicato M; Diederich M
    Ann N Y Acad Sci; 2009 Aug; 1171():436-47. PubMed ID: 19723087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.
    Zhang KZ; Xu JH; Huang XW; Wu LX; Su Y; Chen YZ
    Acta Pharmacol Sin; 2007 Jan; 28(1):105-10. PubMed ID: 17184589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1206, a novel curcumin derivative, potently inhibits Hsp90 and human chronic myeloid leukemia cells in vitro.
    Fan YJ; Zhou YX; Zhang LR; Lin QF; Gao PZ; Cai F; Zhu LP; Liu B; Xu JH
    Acta Pharmacol Sin; 2018 Apr; 39(4):649-658. PubMed ID: 29219946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RITA induces apoptosis in p53-null K562 leukemia cells by inhibiting STAT5, Akt, and NF-κB signaling pathways.
    Mobaraki RN; Karimi M; Alikarami F; Farhadi E; Amini A; Bashash D; Paridar M; Kokhaei P; Rezvani MR; Kazemi A; Safa M
    Anticancer Drugs; 2018 Oct; 29(9):847-853. PubMed ID: 30157040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells.
    Wolanin K; Magalska A; Mosieniak G; Klinger R; McKenna S; Vejda S; Sikora E; Piwocka K
    Mol Cancer Res; 2006 Jul; 4(7):457-69. PubMed ID: 16849521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib.
    Cheng Y; Hao Y; Zhang A; Hu C; Jiang X; Wu Q; Xu X
    Int J Mol Med; 2018 Jan; 41(1):455-463. PubMed ID: 29115375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SWATH-MS based quantitative proteomics analysis reveals that curcumin alters the metabolic enzyme profile of CML cells by affecting the activity of miR-22/IPO7/HIF-1α axis.
    Monteleone F; Taverna S; Alessandro R; Fontana S
    J Exp Clin Cancer Res; 2018 Jul; 37(1):170. PubMed ID: 30045750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells.
    Kwon YK; Jun JM; Shin SW; Cho JW; Suh SI
    Int J Oncol; 2005 Jun; 26(6):1597-603. PubMed ID: 15870875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOLFIRI-Mediated Toxicity in Human Aortic Smooth Muscle Cells and Possible Amelioration with Curcumin and Quercetin.
    Güçlü O; Doğanlar O; Yüksel V; Doğanlar ZB
    Cardiovasc Toxicol; 2020 Apr; 20(2):139-154. PubMed ID: 31278615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Methoxybenzyl 5-Nitroacridone Derivative Effectively Triggers G1 Cell Cycle Arrest in Chronic Myelogenous Leukemia K562 Cells by Inhibiting CDK4/6-Mediated Phosphorylation of Rb.
    Zhang B; Zhang T; Zhang TY; Wang N; He S; Wu B; Jin HX
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saponins from Rubus parvifolius L. induce apoptosis in human chronic myeloid leukemia cells through AMPK activation and STAT3 inhibition.
    Ge YQ; Xu XF; Yang B; Chen Z; Cheng RB
    Asian Pac J Cancer Prev; 2014; 15(13):5455-61. PubMed ID: 25041018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph+ acute lymphoblastic leukemia.
    Guo Y; Li Y; Shan Q; He G; Lin J; Gong Y
    Int J Biochem Cell Biol; 2015 Aug; 65():1-11. PubMed ID: 25979368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.